Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Buckley

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Plos One|July 30, 2020
Birth as a neuro-psycho-social event: An integrative model of maternal experiences and their relation to neurohormonal events during childbirthIbone Olza, Kerstin Uvnas-Moberg, Anette Ekström-Bergström, et al.
Haematologica|June 3, 2018
Patient-reported outcomes and health status associated with chronic graft-<i>versus</i>-host diseaseStephanie J Lee, Lynn Onstad, Eric J Chow, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 21, 2024
Consistency of Spleen and Symptom Reduction Regardless of Cytopenia in Patients With Myelofibrosis Treated With PacritinibNico Gagelmann, Prithviraj Bose, Vikas Gupta, et al.
BMC Pregnancy and Childbirth|March 2, 2023
Maternal and newborn plasma oxytocin levels in response to maternal synthetic oxytocin administration during labour, birth and postpartum - a systematic review with implications for the function of the oxytocinergic systemSarah Buckley, Kerstin Uvnäs-Moberg, Zada Pajalic, et al.
European Journal of Haematology|October 14, 2024
Pacritinib Response Is Associated With Overall Survival in Myelofibrosis: PERSIST-2 Landmark Analysis of SurvivalHelen Ajufo, Jan Philipp Bewersdorf, Claire Harrison, et al.
Cancer|October 27, 2017
PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivorsBronwen E Shaw, Karen L Syrjala, Lynn E Onstad, et al.
Plos One|August 7, 2020
Maternal plasma levels of oxytocin during breastfeeding-A systematic reviewKerstin Uvnäs Moberg, Anette Ekström-Bergström, Sarah Buckley, et al.
BMC Pregnancy and Childbirth|August 11, 2019
Maternal plasma levels of oxytocin during physiological childbirth - a systematic review with implications for uterine contractions and central actions of oxytocinKerstin Uvnäs-Moberg, Anette Ekström-Bergström, Marie Berg, et al.
Ejhaem|December 5, 2022
Risk-adjusted safety analysis of the oral JAK2/IRAK1 inhibitor pacritinib in patients with myelofibrosisNaveen Pemmaraju, Claire Harrison, Vikas Gupta, et al.
JAMA Network Open|December 5, 2022
Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical TrialJohn Cafardi, Carole Miller, Howard Terebelo, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Plos One|July 30, 2020
Birth as a neuro-psycho-social event: An integrative model of maternal experiences and their relation to neurohormonal events during childbirthIbone Olza, Kerstin Uvnas-Moberg, Anette Ekström-Bergström, et al.
Haematologica|June 3, 2018
Patient-reported outcomes and health status associated with chronic graft-<i>versus</i>-host diseaseStephanie J Lee, Lynn Onstad, Eric J Chow, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 21, 2024
Consistency of Spleen and Symptom Reduction Regardless of Cytopenia in Patients With Myelofibrosis Treated With PacritinibNico Gagelmann, Prithviraj Bose, Vikas Gupta, et al.
BMC Pregnancy and Childbirth|March 2, 2023
Maternal and newborn plasma oxytocin levels in response to maternal synthetic oxytocin administration during labour, birth and postpartum - a systematic review with implications for the function of the oxytocinergic systemSarah Buckley, Kerstin Uvnäs-Moberg, Zada Pajalic, et al.
European Journal of Haematology|October 14, 2024
Pacritinib Response Is Associated With Overall Survival in Myelofibrosis: PERSIST-2 Landmark Analysis of SurvivalHelen Ajufo, Jan Philipp Bewersdorf, Claire Harrison, et al.
Cancer|October 27, 2017
PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivorsBronwen E Shaw, Karen L Syrjala, Lynn E Onstad, et al.
Plos One|August 7, 2020
Maternal plasma levels of oxytocin during breastfeeding-A systematic reviewKerstin Uvnäs Moberg, Anette Ekström-Bergström, Sarah Buckley, et al.
BMC Pregnancy and Childbirth|August 11, 2019
Maternal plasma levels of oxytocin during physiological childbirth - a systematic review with implications for uterine contractions and central actions of oxytocinKerstin Uvnäs-Moberg, Anette Ekström-Bergström, Marie Berg, et al.
Ejhaem|December 5, 2022
Risk-adjusted safety analysis of the oral JAK2/IRAK1 inhibitor pacritinib in patients with myelofibrosisNaveen Pemmaraju, Claire Harrison, Vikas Gupta, et al.
JAMA Network Open|December 5, 2022
Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical TrialJohn Cafardi, Carole Miller, Howard Terebelo, et al.
Pageof 3